Dr Martens /£DOCS
08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX
About Dr Martens
Dr. Martens, also known as Docs or DMs, is a United Kingdom-based company renowned for its iconic range of footwear, alongside a variety of clothing and accessories. The company, headquartered in Wollaston, Northamptonshire, operates primarily in the footwear manufacturing sector. Established in 1947, Dr. Martens has grown to become a symbol of self-expression and counterculture, distributing its products worldwide under the Dr. Martens brand.
Ticker
£DOCS
Sector
Primary listing
LSE
Employees
3,700
Headquarters
Website
Dr Martens Metrics
BasicAdvanced
£714M
47.51
£0.02
0.23
£0.03
3.47%
Price and volume
Market cap
£714M
Beta
0.23
52-week high
£1.01
52-week low
£0.43
Average daily volume
1.2M
Dividend rate
£0.03
Financial strength
Current ratio
2.18
Quick ratio
1.082
Long term debt to equity
105.591
Total debt to equity
120.662
Dividend payout ratio (TTM)
115.69%
Interest coverage (TTM)
2.30%
Profitability
EBITDA (TTM)
80.9
Gross margin (TTM)
65.52%
Net profit margin (TTM)
1.95%
Operating margin (TTM)
8.51%
Effective tax rate (TTM)
42.26%
Revenue per employee (TTM)
£210,000
Management effectiveness
Return on assets (TTM)
4.64%
Return on equity (TTM)
4.61%
Valuation
Price to earnings (TTM)
47.507
Price to revenue (TTM)
0.926
Price to book
2.17
Price to tangible book (TTM)
12.73
Price to free cash flow (TTM)
5.199
Free cash flow yield (TTM)
19.23%
Free cash flow per share (TTM)
0.141
Dividend yield (TTM)
3.47%
Growth
Revenue change (TTM)
-2.59%
Earnings per share change (TTM)
-49.24%
3-year revenue growth (CAGR)
-6.39%
3-year earnings per share growth (CAGR)
-55.65%
3-year dividend per share growth (CAGR)
-24.13%
What the Analysts think about Dr Martens
Analyst ratings (Buy, Hold, Sell) for Dr Martens stock.
Dr Martens Financial Performance
Revenues and expenses
Dr Martens Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Dr Martens stock?
Dr Martens (DOCS) has a market cap of £714M as of November 24, 2025.
What is the P/E ratio for Dr Martens stock?
The price to earnings (P/E) ratio for Dr Martens (DOCS) stock is 47.51 as of November 24, 2025.
Does Dr Martens stock pay dividends?
Yes, the Dr Martens (DOCS) stock pays dividends to shareholders. As of November 24, 2025, the dividend rate is £0.0255 and the yield is 3.47%. Dr Martens has a payout ratio of 115.69% on a trailing twelve-month basis.
When is the next Dr Martens dividend payment date?
The next Dr Martens (DOCS) dividend payment is scheduled for April 09, 2026.
What is the beta indicator for Dr Martens ?
Dr Martens (DOCS) has a beta rating of 0.23. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.